Thomson Medical: halt to be lifted at 9am.
Peter Lim, via pte invmt vehicle Sasteria, acquires 39.3% stake from founder, Dr Cheng Wei Chen; triggers mandatory offer for remaining shares. Offer price at $1.75/sh is at 62% premium over last traded at $1.08, values the obstetrics and gynae svc provider at $513m. Cash offer is conditional on Peter Lim acquiring >50% stake…
Peter Lim, which owns ~30% interest in Msia’s TMC Life Sciences, a healthcare svc provider specializing in fertility treatment, stem cell banking and stem cell therapy, notes the potential to develop Thomson further as a regional healthcare company. Says prospects to be underpinned by the growing population and affluence in the region, increasing demand for private healthcare services.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment